Abstract:BACKGROUND:Neuropathic pain is a complex state of chronic pain that is usually accompanied by peripheral and central nervous system damage or dysfunction. Previous studies have indicated that neuroinflammation in the spinal cord is an important contributor to neuropathological and behavioral abnormalities. A series of early inflammatory markers, such as IL-1, TNF-α, and IFN-γ, and advanced inflammatory markers, such as high-mobility group box 1 (HMGB1), are involved in neuroinflammation.STUDY DESIGN:A randomized, double blind, controlled animal trial.OBJECTIVE:In this study, a lentivirus delivering human IL-10 (LV/hIL-10) was administered intrathecally to determine the effects of IL-10 on allodynia and hyperalgesia in a chronic constriction injury-induced (CCI) rat model of neuropathic pain.METHODS:Sprague-Dawley rats weighting 260 - 320 g were randomly divided into 4 groups. Group Sham (Sham), Group CCI±Normal Saline (NS), Group CCI±LV/hIL-10 (LV/hIL-10), and Group CCI±LV/control (vector). Rats in each group were intrathecally delivered with NS, LV/control, or recombinant vector LV/hIL-10 in a total volume of 10 μl. Paw withdrawal mechanical thresholds (PWMT) and paw withdrawal thermal latency PWTL were measured one day before CCI (baseline) and 0, 3, 7, 14, and 28 days after intrathecal administration. Cerebrospinal fluid (CSF) samples were collected during surgical plane anesthesia and the collected CSF samples were used to assay for human IL-10, rat IL-1β, rat IL-6, and rat TNF-α by enzyme-linked immunosorbent assay (ELISA). Animals were sacrificed and the L4-5 lumbar segment of the spinal cord was removed for determination of green fluorescent protein (GFP) expression. Immunohistochemical analysis was performed using anti HMGB1 antibodies and the expression of HMGB1 protein in the spinal cord was determined by western blot analysis after intrathecal delivery (n = 8 each).RESULTS:The results show that intrathecal LV/hIL-10 reverses enhanced pain states. Moreover, the increased level of HMGB1 exhibited in a late stage of CCI was inhibited by exogenous overexpression of hIL-10 in the CCI model. Expression of HMGB1, RAGE, and pAkt were lower in CCI-induced rats treated with LV/hIL-10 than in those treated with LV/control (vector) or saline (NS). Our results showed that IL-10 inhibits activation of the inflammatory HMGB1-RAGE pathway in the CCI rat model.LIMITATIONS:Further experimental investigations are needed to clarify the specific biological roles played by HMGB1 in IL-10-mediated regulation of neuropathic pain.CONCLUSION:Our results indicate that intrathecal lentiviral-mediated transfer of IL-10 attenuates CCI-induced neuropathic pain in rats. The anti-thermal hyperalgesia and anti-mechanical allodynia may be partly attributable to the decreased expression of HMGB1 and inhibition of HMGB1-RAGE pathway.

Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons.

Interleukin-10 Inhibits Angiotensin II-induced Decrease in Neuronal Potassium Current

Axotomy-Induced Up-Regulation of Tumor Necrosis Factor-Alpha in the Dorsal Root Ganglia

Intrathecal Lentivirus-Mediated Transfer of Interleukin-10 Attenuates Chronic Constriction Injury-Induced Neuropathic Pain Through Modulation of Spinal High-Mobility Group Box 1 in Rats.

TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury

The Up-Regulation of IL-6 in DRG and Spinal Dorsal Horn Contributes to Neuropathic Pain Following L5 Ventral Root Transection

TNF-α Enhances the Currents of Voltage Gated Sodium Channels in Uninjured Dorsal Root Ganglion Neurons Following Motor Nerve Injury

Upregulation of Interleukin-6 on Cav3.2 T-type Calcium Channels in Dorsal Root Ganglion Neurons Contributes to Neuropathic Pain in Rats with Spinal Nerve Ligation.

IL-10 and IL-1β Mediate Neuropathic-Pain Like Behavior in the Ventrolateral Orbital Cortex

Upregulation of transcription factor 4 downregulates Na<sub>v</sub>1.8 expression in DRG neurons and prevents the development of rat inflammatory and neuropathic hypersensitivity

Inhibition of NF-kappaB Prevents Mechanical Allodynia Induced by Spinal Ventral Root Transection and Suppresses the Re-Expression of Nav1.3 in DRG Neurons in Vivo and in Vitro.

Interleukin 33-mediated inhibition of A-type K<SUP>+</SUP> channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice

Interleukin-1β Induces Long-Term Potentiation of C-Fiber Evoked Field Potentials in Spinal Dorsal Horn in Rats with Neuropathic Pain

Effects of Intrathecally Administerd NaV1.8 Antisense Oligonucleotide on the Expression of Sodium Channel Mrna in Dorsal Root Ganglion

Interleukin 33-mediated inhibition of A-type K + channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice

Small Interfering RNA-mediated Selective Knockdown of NaV1.8 Tetrodotoxin-Resistant Sodium Channel Reverses Mechanical Allodynia in Neuropathic Rats

Upregulation of N-type Calcium Channels in the Soma of Uninjured Dorsal Root Ganglion Neurons Contributes to Neuropathic Pain by Increasing Neuronal Excitability Following Peripheral Nerve Injury.

Interleukin-10 gene therapy for neuropathic pain in a rat model of chronic constriction injury

Dual Modulation of Interleukin-1 Beta on Tetrodotoxin-Sensitive Sodium Currents in Mice Trigeminal Ganglion Cells

Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues

TNF-α/STAT3 pathway epigenetically upregulates Nav1.6 expression in DRG and contributes to neuropathic pain induced by L5-VRT